SCHEMBL3851753

SCHEMBL3851753

CCCCN1CCC(O)(c2cccc(C(F)(F)F)c2F)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UBE2M P61081 1/20 0.45
DCUN1D1 Q96GG9 1/20 0.45
SIGMAR1 Q99720 8/20 0.44
EBP Q15125 2/20 0.43
DRD2 P14416 7/20 0.42
CCR1 P32246 1/20 0.41
HTR1A P08908 5/20 0.41
DRD4 P21917 5/20 0.41
HRH2 P25021 5/20 0.41
HTR2A P28223 5/20 0.41
HTR2C P28335 5/20 0.41
HTR7 P34969 5/20 0.41
OPRM1 P35372 5/20 0.41
OPRK1 P41145 5/20 0.41
DRD3 P35462 4/20 0.41
HTR2B P41595 4/20 0.41
HTR1D P28221 4/20 0.41
DRD1 P21728 3/20 0.41
DRD5 P21918 3/20 0.41
SLC6A2 P23975 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2783423 0.93 LMNA (0.44) UBE2MDCUN1D1SIGMAR1EBPDRD2
SCHEMBL3853355 0.89 DRD2 (0.43) SIGMAR1EBPDRD2CCR1HTR1A
SCHEMBL3772165 0.87 OPRL1 (0.39) DRD2CCR1OPRM1OPRK1OPRD1
SCHEMBL3853965 0.85 OPRM1 (0.43) SIGMAR1EBPDRD2CCR1HTR1A
SCHEMBL3853446 0.84 DRD2 (0.42) DRD2CCR1HTR1ADRD4HRH2
SCHEMBL3769750 0.83 OPRD1 (0.38) OPRM1OPRK1OPRD1CYP3A4CYP2D6
SCHEMBL3849563 0.79 DRD2 (0.45) DRD2CCR1HTR1ADRD4HRH2
SCHEMBL5501040 0.79 FPR3 (0.40) SIGMAR1EBPDRD2CCR1HTR1A
SCHEMBL13632588 0.79 DRD2 (0.43) SIGMAR1EBPDRD2CCR1DRD4
SCHEMBL27705624 0.78 OPRM1 (0.40) OPRM1OPRK1OPRD1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101076517-B Substituted piperidines as modulators of dopamine neurotransmission NSAB AF NEUROSEARCH SWEDEN AB 2010-12-15 CN claimed
CN-101076517-B Substituted piperidines as modulators of dopamine neurotransmission NSAB AF NEUROSEARCH SWEDEN AB 2010-12-15 CN disclosed
EP-1765779-B1 NEW SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION NSAB AF NEUROSEARCH SWEDEN AB (DK) 2009-11-18 EP disclosed
EP-1765779-B1 NEW SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION NSAB AF NEUROSEARCH SWEDEN AB (DK) 2009-11-18 EP disclosed
US-7579474-B2 Substituted piperidines as modulators of dopamine neurotransmission NSAB, FILIAL AF NEUROSEARCH AB, SVERIGE (DK) 2009-08-25 US disclosed
US-7579474-B2 Substituted piperidines as modulators of dopamine neurotransmission NSAB, FILIAL AF NEUROSEARCH AB, SVERIGE (DK) 2009-08-25 US disclosed
US-7579474-B2 Substituted piperidines as modulators of dopamine neurotransmission NSAB, FILIAL AF NEUROSEARCH AB, SVERIGE (DK) 2009-08-25 US disclosed
US-20070270467-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2007-11-22 US disclosed
US-20070270467-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2007-11-22 US disclosed
US-20070270467-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2007-11-22 US disclosed
CN-101076517-A Novel substituted piperidines as modulators of dopamine neurotransmission CARLSSON A RESEARCH AB (SE) 2007-11-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270467-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION DRD2, PRLHR, DRD3 UBE2M 3599/4885DCUN1D1 1663/4885SIGMAR1 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.